Pacira BioSciences (PCRX) Common Equity (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Common Equity of $653.9 million for Q1 2026, down 18.11% year-over-year from $798.5 million in Q1 2025, and down 5.66% quarter-over-quarter from $693.1 million in Q4 2025.
Pacira BioSciences (PCRX) Common Equity (2010 - 2026) Analysis & Trends
Pacira BioSciences' Common Equity history runs 17 years deep, the most recent figure standing at $653.9 million for Q1 2026.
- In Q1 2026, Common Equity fell 18.11% year-over-year to $653.9 million; the TTM figure through Mar 2026 stood at $653.9 million (down 18.11% YoY), while the FY2025 annual figure was $693.1 million, down 10.95% from the prior year.
- Common Equity for Q1 2026 stood at $653.9 million, down from $693.1 million in the prior quarter.
- The five-year high for Common Equity was $892.2 million in Q1 2024, with the low at $653.9 million in Q1 2026.
- The 5-year median for Common Equity is $770.1 million (2022), against an average of $777.6 million.
- The sharpest annual moves came in 2024 and 2026: Common Equity gained 16.16% in 2024, then decreased 18.11% in 2026.
- Pacira BioSciences' Common Equity stood at $775.0 million in 2022, then gained by 12.27% to $870.1 million in 2023, then decreased by 10.55% to $778.3 million in 2024, then retreated by 10.95% to $693.1 million in 2025, then decreased by 5.66% to $653.9 million in 2026.
- Business Quant data shows PCRX's Common Equity at $653.9 million in Q1 2026, $693.1 million in Q4 2025, and $727.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 4.05 Bn |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 671.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 671.98 Mn |
| Mar 31, 2026 | 653.89 Mn |
| Dec 31, 2025 | 693.11 Mn |
| Sep 30, 2025 | 727.21 Mn |
| Jun 30, 2025 | 757.77 Mn |
| Mar 31, 2025 | 798.54 Mn |
| Dec 31, 2024 | 778.35 Mn |
| Sep 30, 2024 | 749.58 Mn |
| Jun 30, 2024 | 879.28 Mn |
| Mar 31, 2024 | 892.16 Mn |
| Dec 31, 2023 | 870.13 Mn |
| Sep 30, 2023 | 831.55 Mn |
| Jun 30, 2023 | 807.98 Mn |
| Mar 31, 2023 | 768.04 Mn |
| Dec 31, 2022 | 775.01 Mn |
| Sep 30, 2022 | 770.12 Mn |
| Jun 30, 2022 | 756.64 Mn |
| Mar 31, 2022 | 709.58 Mn |
| Dec 31, 2021 | 730.41 Mn |
| Sep 30, 2021 | 718.60 Mn |